Glaxo nears $3 billion deal for U.S. dermatology drug maker: WSJ

GlaxoSmithKline is close to a deal to buy Stiefel Laboratories, a closely held U.S. maker of dermatology products, for about $3 billion, The Wall Street Journal reports.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.